News Articles
Latest articles, insights, and updates from the blog.
Contact Ketamine Troche
Send corrections, provider questions, or advertising inquiries.
Why 'Difficult-to-Treat' May Replace 'Treatment-Resistant'
Psychiatry may retire 'treatment-resistant depression' for 'difficult-to-treat.' Here's what that shift means for ketamine troche users.
A Ketamine Awakening Story Highlights Therapy Risks
A Canberra Times account of ketamine changing a first-time user's life raises questions about misuse vs. supervised troche therapy.
Veterans Gain New Ketamine PTSD Treatment Path
Veterans may get a new ketamine option for PTSD, per a September 2026 report. Here's what's confirmed, what's unclear, and what to ask your provider.
Nerve Pain 'Worse Than Death': Can Ketamine Help?
A Toronto Star report examines ketamine as a treatment for severe nerve pain. Here's what it means for troche dosing, safety, and treatment options.
Ketamine Eases Treatment-Resistant Bipolar Depression
A new report finds ketamine reduced depressive symptoms in treatment-resistant bipolar depression. Here's what it means for troche users and clinicians.
VA's Only Depression Drug Needs 50 Visits a Year
VA's only approved treatment-resistant depression drug can demand up to 50 visits a year. Here's what that access burden means for ketamine troche care.
Missouri's First Ketamine Clinic Eyes What's Next
Missouri Independent reports on the state's first ketamine therapy practice. Here's what its expansion could mean for troche access and dosing.
Ketamine Plus Psychotherapy Shows Promise for Nerve Pain
New reporting highlights ketamine paired with psychotherapy for chronic neuropathic pain, and what it could mean for troche-based dosing routines.
Treatment-Resistant Depression: Where Ketamine Fits In
STAT explores next steps when antidepressants fail. Here's how ketamine troches fit into treatment-resistant depression care, from dosing to safety.
Federal Officials Probe Online Ketamine Sellers
Federal officials are investigating online ketamine sellers to limit at-home use. Here's what troche patients and telehealth ketamine users need to know.
FDA Moves Against Illegal Ketamine Sellers in 2026
The FDA is targeting illegal ketamine sellers in 2026. Here's what this enforcement action means for patients using compounded ketamine troches.
Ketamine Research: Hope for Resistant Depression Patients
New research highlights ketamine's rapid antidepressant effects in treatment-resistant depression and suicidal ideation, what troche patients need to know.
Esketamine Nasal Spray vs. Troches: What TRD Data Shows
Psychiatric Times reviews esketamine nasal spray safety for TRD and MDD, key findings and what ketamine troche patients should know.